Literature DB >> 15090551

Bone morphogenetic protein type IA receptor signaling regulates postnatal osteoblast function and bone remodeling.

Yuji Mishina1, Michael W Starbuck, Michael A Gentile, Tomokazu Fukuda, Viera Kasparcova, J Gregory Seedor, Mark C Hanks, Michael Amling, Gerald J Pinero, Shun-ichi Harada, Richard R Behringer.   

Abstract

Bone morphogenetic proteins (BMPs) function during various aspects of embryonic development including skeletogenesis. However, their biological functions after birth are less understood. To investigate the role of BMPs during bone remodeling, we generated a postnatal osteoblast-specific disruption of Bmpr1a that encodes the type IA receptor for BMPs in mice. Mutant mice were smaller than controls up to 6 months after birth. Irregular calcification and low bone mass were observed, but there were normal numbers of osteoblasts. The ability of the mutant osteoblasts to form mineralized nodules in culture was severely reduced. Interestingly, bone mass was increased in aged mutant mice due to reduced bone resorption evidenced by reduced bone turnover. The mutant mice lost more bone after ovariectomy likely resulting from decreased osteoblast function which could not overcome ovariectomy-induced bone resorption. In organ culture of bones from aged mice, ablation of the Bmpr1a gene by adenoviral Cre recombinase abolished the stimulatory effects of BMP4 on the expression of lysosomal enzymes essential for osteoclastic bone resorption. These results demonstrate essential and age-dependent roles for BMP signaling mediated by BMPRIA (a type IA receptor for BMP) in osteoblasts for bone remodeling.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15090551     DOI: 10.1074/jbc.M404222200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  86 in total

Review 1.  Building strong bones: molecular regulation of the osteoblast lineage.

Authors:  Fanxin Long
Journal:  Nat Rev Mol Cell Biol       Date:  2011-12-22       Impact factor: 94.444

2.  Impacts of age and gender on bone marrow profiles of BMP7, BMPRs and Stro-1⁺ cells in patients with total hip replacement.

Authors:  Yi Shen; Weili Wang; Xiaomiao Li; Zude Liu; David C Markel; Weiping Ren
Journal:  Int Orthop       Date:  2011-11-03       Impact factor: 3.075

Review 3.  Signaling pathways affecting skeletal health.

Authors:  Pierre J Marie
Journal:  Curr Osteoporos Rep       Date:  2012-09       Impact factor: 5.096

4.  c-Abl promotes osteoblast expansion by differentially regulating canonical and non-canonical BMP pathways and p16INK4a expression.

Authors:  Hui-Yi Kua; Huijuan Liu; Wai Fook Leong; Lili Li; Deyong Jia; Gang Ma; Yuanyu Hu; Xueying Wang; Jenny F L Chau; Ye-Guang Chen; Yuji Mishina; Sharon Boast; James Yeh; Li Xia; Guo-Qiang Chen; Lin He; Stephen P Goff; Baojie Li
Journal:  Nat Cell Biol       Date:  2012-06-24       Impact factor: 28.824

5.  Extracellular microfibrils control osteoblast-supported osteoclastogenesis by restricting TGF{beta} stimulation of RANKL production.

Authors:  Harikiran Nistala; Sui Lee-Arteaga; Silvia Smaldone; Gabriella Siciliano; Francesco Ramirez
Journal:  J Biol Chem       Date:  2010-08-21       Impact factor: 5.157

6.  Physiological role of bone morphogenetic proteins in osteogenesis.

Authors:  Fumitaka Kugimiya; Shinsuke Ohba; Kozo Nakamura; Hiroshi Kawaguchi; Ung-Il Chung
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

Review 7.  Molecular genetic studies of gene identification for osteoporosis: a 2004 update.

Authors:  Yong-Jun Liu; Hui Shen; Peng Xiao; Dong-Hai Xiong; Li-Hua Li; Robert R Recker; Hong-Wen Deng
Journal:  J Bone Miner Res       Date:  2006-10       Impact factor: 6.741

8.  Loss of BMPR2 leads to high bone mass due to increased osteoblast activity.

Authors:  Jonathan W Lowery; Giuseppe Intini; Laura Gamer; Sutada Lotinun; Valerie S Salazar; Satoshi Ote; Karen Cox; Roland Baron; Vicki Rosen
Journal:  J Cell Sci       Date:  2015-02-06       Impact factor: 5.285

9.  The pro-osteogenic action of beta-catenin requires interaction with BMP signaling, but not Tcf/Lef transcriptional activity.

Authors:  Valerie S Salazar; Gabriel Mbalaviele; Roberto Civitelli
Journal:  J Cell Biochem       Date:  2008-06-01       Impact factor: 4.429

10.  SM22alpha-targeted deletion of bone morphogenetic protein receptor 1A in mice impairs cardiac and vascular development, and influences organogenesis.

Authors:  Nesrine El-Bizri; Christophe Guignabert; Lingli Wang; Alexander Cheng; Kryn Stankunas; Ching-Pin Chang; Yuji Mishina; Marlene Rabinovitch
Journal:  Development       Date:  2008-07-30       Impact factor: 6.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.